ArticleThe Thoracic and cardiovascular surgeon2022
Video-Assisted Thoracoscopic Segmentectomy for Deep and Peripheral Small Lung Cancer.
Article in The Thoracic and cardiovascular surgeon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prognostic value of consolidation-to-tumor ratio on computed tomography in NSCLC: a meta-analysis.World journal of surgical oncology · 2023Pooled it
- Dye Localization Extended Segmentectomy vs. Lobectomy for Deep Intersegmental Early-Stage Lung Cancer.Diagnostics (Basel, Switzerland) · 2026Article
- Anatomical Sublobar Resection for Multi-Intersegmental Pulmonary Nodules.Thoracic cancer · 2026Article
- Lobectomy is the preferred choice rather than sublobar resection for centrally located clinical stage 1 non-small cell lung cancer.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2025Article
- Segmental bronchial marking method using indocyanine green for safe thoracoscopic segmentectomy: a single-center early experience.Journal of thoracic disease · 2025Article
- Salivary metabolites as potential predictive biomarkers for lung surgery complications: a retrospective cross-sectional study.Surgery today · 2024Article
- [Impact of the Size and Depth of Pulmonary Nodules on the Surgical Approach for Lung Resection in the Treatment of Early-stage Lung Cancer ≤2 cm].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2024Article
- Effect of pulmonary rehabilitation training on postoperative recovery in lung cancer patients undergoing thoracoscopic partial pulmonary resection: a meta-analysis.American journal of translational research · 2024Review
- Review
- Three-Dimensional Guided Cone-Shaped Segmentectomy Versus Lobectomy for Small-sized Non-Small Cell Lung Cancer in the Middle Third of the Lung Field.Annals of surgical oncology · 2023Article
- ASO Author Reflections: Three-Dimensional-Guided Segmentectomy can be an Alternative to Lobectomy for Small-Sized Non-small Cell Lung Cancer in the Middle-Third Lung Parenchyma.Annals of surgical oncology · 2023Article
- Commentary: Validation of Sublobar Resection for Middle Third Tumors: Advanced Imaging Technology Affords Patients a Viable Alternative to Lobectomy.Annals of surgical oncology · 2023Article
- Combined basilar subsegmentectomy for intralobar sequestration via uniportal VATS: a case report.Surgical case reports · 2023Article
- Thoracoscopic "cut-through" segmentectomy for small-sized lung cancer in a deep central location.Thoracic cancer · 2022Article
- Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: a study based on the SEER database and a Chinese cohort.BMC cancer · 2022Article
- Editorial: Strategies of Lymph Node Dissection During Sublobar Resection for Early Stage Lung Cancer.Frontiers in surgery · 2022Article
- Strategies of Lymph Node Dissection During Sublobar Resection for Early-Stage Lung Cancer.Frontiers in surgery · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe aimed to retrospectively compare the long-term prognosis and recurrence after segmentectomy between nonsmall cell lung cancer (NSCLC) patients with deep and peripheral lesions.
methodsData were extracted for 85 lobectomy-tolerable NSCLC patients with tumors measuring ≤2 cm, who underwent video-assisted thoracoscopic segmentectomy with curative intent during January 2006 to December 2014. Tumor location was determined by the surgeon using thin-slice (1 mm) and three-dimensional computed tomography. Overall and recurrence-free survival was compared between patients with peripheral and deep lesions using univariate and multivariate Cox proportional hazard models. The indications for segmentectomy included NSCLC measuring ≤2 cm and consolidation/tumor ratio ≤20%, solid NSCLC ≤1 cm, and indeterminate nodule ≤1.5 cm.
resultsNo recurrence of peripheral and deep lesions was noted. The 5-year overall survival was 96.4% for all patients, and 100 and 95.3% for patients with deep and peripheral lesions, respectively. There was no significant difference between the overall survival rates associated with the deep and peripheral lesions (95% confidence interval [CI], 89.5-98.8, nonsignificant, 86.4-98.4, respectively;
conclusionsWhen video-assisted thoracoscopic segmentectomy with curative intent was performed with sufficient surgical margins, the location of small NSCLC did not affect recurrence risk and prognosis. Video-assisted thoracoscopic segmentectomy for small NSCLC is acceptable, regardless of the tumor location.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.